Liarozole
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 6-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-1,3-benzimidazole  | |
| Identifiers | |
CAS Number  | 
|
3D model (JSmol)  | 
|
| ChemSpider | |
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C17H13ClN4 | 
| Molar mass | 308.77 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Liarozole is a retinoic acid metabolism-blocking drug and aromatase inhibitor.[1] Liarozole is an isomer of alprazolam, but the two compounds are completely unrelated.
References
- ↑ Vahlquist, A; Blockhuys, S; Steijlen, P; Van Rossem, K; Didona, B; Blanco, D; Traupe, H (2013). "Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial". The British Journal of Dermatology. 170 (1): 173–81. doi:10.1111/bjd.12626. PMC 4232915. PMID 24102348.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
